ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Emerging growth company
|
Smaller reporting company
|
Auditor Name: |
Auditor Location: |
PCAOB ID:
|
Item 15.
|
Exhibits and Financial Statement Schedules
|
(1) |
Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of the Original Annual Report.
|
(2) |
Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the
absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto.
|
(3) |
Exhibits:
The documents listed in the Exhibit Index of this Amendment No. 1 to the Annual Report on Form 10-K/A are incorporated by reference or are filed with this Amendment No. 1 to the Annual Report on Form 10-K/A, in each case as indicated
therein (numbered in accordance with Item 601 of Regulation S-K).
|
Exhibit
Number
|
Description
|
Incorporated by reference herein
|
||||
Form
|
Exhibit
No.
|
Filing Date
|
File No.
|
Filed
Herewith |
||
3.1
|
8-K
|
3.1
|
11/01/2007
|
000-26895
|
||
3.2
|
8-K
|
3.1
|
10/25/2023
|
001-33852
|
||
3.3
|
8-K
|
3.1
|
1/27/2023
|
001-33852
|
||
4.2
|
S-3
|
4.1
|
07/30/2018
|
333-226413
|
||
4.3
|
S-3
|
4.2
|
07/30/2018
|
333-226413
|
||
4.4
|
S-3
|
4.4
|
07/30/2018
|
333-226413
|
||
4.5
|
10-K
|
4.6
|
03/16/2020
|
001-33852
|
||
10.1
|
10-K
|
10.1
|
03/18/2019
|
001-33852
|
||
10.2*
|
10-Q
|
10.2
|
05/10/2012
|
001-33852
|
||
10.3*
|
10-Q
|
4.5
|
05/10/2011
|
001-33852
|
||
10.4*
|
10-Q
|
10.3
|
05/10/2012
|
001-33852
|
||
10.5*
|
DEF 14A
|
Appendix A
|
04/13/2021
|
001-33852
|
||
10.6*
|
S-8
|
10.1
|
06/15/2023
|
333-272677
|
||
10.7*
|
10-K
|
10.6
|
03/02/2015
|
001-33852
|
||
10.8*
|
10-K
|
10.7
|
03/02/2015
|
001-33852
|
||
10.9*
|
10-Q
|
10.2
|
08/11/2023
|
001-33852
|
||
10.10
|
8-K
|
10.4
|
07/12/2007
|
000-26895
|
||
10.11**
|
8-K
|
10.6
|
07/12/2007
|
000-26895
|
||
10.12
|
8-K
|
10.1
|
03/18/2008
|
001-33852
|
||
10.13
|
8-K
|
10.5
|
07/12/2007
|
000-26895
|
||
10.14
|
8-K
|
10.7
|
07/12/2007
|
000-26895
|
||
10.15
|
8-K
|
10.8
|
07/12/2007
|
000-26895
|
||
10.16**
|
10-Q/A
|
10.1
|
01/31/2011
|
001-33852
|
||
10.17**
|
10-K
|
10.23
|
03/02/2015
|
001-33852
|
||
10.18*
|
10-Q
|
10.1
|
11/08/2021
|
001-33852
|
||
10.19*
|
X
|
10.20
|
8-K
|
10.1
|
03/30/2023
|
001-33852
|
||
10.21
|
10-Q
|
10.2
|
05/15/2023
|
001-33852
|
||
10.22*
|
X
|
|||||
21.1
|
10-K
|
21.1
|
03/16/2021
|
001-33852
|
||
23.1
|
10-K
|
23.1
|
3/15/2024
|
001-33852
|
||
24.1
|
10-K
|
24.1
|
3/15/2024
|
001-33852
|
||
31.1
|
10-K
|
31.1
|
3/15/2024
|
001-33852
|
||
31.2
|
10-K
|
31.2
|
3/15/2024
|
001-33852
|
||
31.3
|
X
|
|||||
31.4
|
X
|
|||||
32.1†
|
10-K
|
32.1
|
3/15/2024
|
001-33852
|
||
32.2†
|
10-K
|
32.2
|
3/15/2024
|
001-33852
|
||
97.1*
|
X
|
|||||
101.INS
|
XBRL Instance Document
|
X
|
||||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
X
|
||||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
X
|
||||
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
X
|
||||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
X
|
||||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|||||
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
X
|
* |
Indicates management contract or compensatory plan.
|
** |
Confidential treatment has been granted by the SEC as to certain portions of this exhibit.
|
*** |
Portions of this exhibit have been omitted pending a determination by the SEC as to whether these portions should be granted confidential treatment.
|
† |
The certifications attached as Exhibit 32.1 and 32.2 that accompany this Report are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing
of VirnetX Holding Corporation under the Securities Act or the Exchange Act, whether before or after the date of this Report, irrespective of any general incorporation language contained in such filing.
|
VirnetX Holding Corporation
|
||
By:
|
/s/ Kendall Larsen
|
|
Name: Kendall Larsen
|
||
Title: Chief Executive Officer and President
|
||
Dated: April 18, 2024
|